Near-Infrared and Red-Light Photobiomodulation for Ocular Aging and Diseases: A Narrative Review

June 2026 in “ Ophthalmology and Therapy ”

Ethan Waisberg, Joshua Ong, Luke Yaldo, Rahul Kumar, Wei Wang, Valerio Calabresi, Giulia Coco, Francisco Gonzalez-Lima, Andrew G. Lee, Giuseppe Giannaccare

Studysummary This review concluded that near-infrared and red light photobiomodulation shows potential for certain ocular conditions like age-related macular degeneration and dry eye disease, but clinical evidence is still mixed and insufficient to establish it as a standard therapy.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

Clinically Significant Axial Shortening in Myopic Children After Repeated Low-Level Red Light Therapy: A Retrospective Multicenter Analysis

research Clinically Significant Axial Shortening in Myopic Children After Repeated Low-Level Red Light Therapy: A Retrospective Multicenter Analysis

37 citations , January 2023 in “Ophthalmology and Therapy”

In this study, more than 25% of children experienced axial length shortening greater than 0.05 mm/year following repeated low-level red-light therapy.

research Low-Level Light/Laser Therapy Versus Photobiomodulation Therapy

433 citations , April 2015 in “Photomedicine and laser surgery”

This editorial discusses the terminology and distinctions between Low-Level Light/Laser Therapy and Photobiomodulation Therapy but reports no new clinical findings.